A prospective observational comparative study on fetomaternal outcome and complications in obstetric patients with sickle cell disease or trait
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253886Keywords:
Anemia, Fetomaternal outcomes, Pregnancy complications, Preterm labor, Sickle cell disease, Sickle cell traitAbstract
Background: Sickle cell disease (SCD) and sickle cell trait (SCT) are associated with increased fetomaternal morbidity and mortality, particularly in endemic regions like central India. Despite improved obstetric care, adverse outcomes persist, especially in endemic regions of central India.
Methods: This prospective observational comparative study was conducted at the department of obstetrics and gynaecology, IGGMC and Mayo Hospital, Nagpur, from January 2023 to July 2024. A total of 190 pregnant women (95 with SCD/SCT and 95 controls with normal haemoglobin) were enrolled. Maternal and fetal outcomes were assessed and compared. Statistical analysis included Chi-square test and student’s t-test, with p<0.05 considered significant.
Results: Women with SCD had significantly higher rates of preeclampsia, severe anemia, and sickle cell crises compared with controls. Fetal outcomes such as intrauterine growth restriction, low birth weight, and preterm delivery were also significantly more frequent in the study group (p<0.05). Cesarean delivery and blood transfusion requirements were higher in SCD cases.
Conclusions: SCD and SCT adversely affect pregnancy outcomes, underscoring the need for multidisciplinary antenatal care, universal screening for sickle cell disease and delivery at tertiary care centres in endemic regions.
Metrics
References
Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142-51. DOI: https://doi.org/10.1016/S0140-6736(12)61229-X
Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018-31. DOI: https://doi.org/10.1016/S0140-6736(10)61029-X
Oteng-Ntim E, Ayensah B, Knight M, Howard J. Pregnancy outcome in patients with sickle cell disease in the UK- a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease. Br J Haematol. 2015;169(1):129-37. DOI: https://doi.org/10.1111/bjh.13270
Sun PM, Wilburn W, Raynor BD, Jamieson D. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol. 2001;184(6):1127-30. DOI: https://doi.org/10.1067/mob.2001.115477
Desai G, Anand A. Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, India. J Health Popul Nutr. 2017;3(36):1-13. DOI: https://doi.org/10.1186/s41043-017-0079-z
Kose V, Kose S. Pregnancy outcome in women with sickle cell disease/trait in a tertiary care hospital Nagpur, Maharashtra India: a descriptive cross sectional study. Int J Reprod Contracept Obstet Gynecol. 2019;8(10):3943-9. DOI: https://doi.org/10.18203/2320-1770.ijrcog20194359
Nwafor JI, Ugoji DP, Ibo CC, Onwe BI, Onuchukwu VJ, Obi CN, et al. Pregnancy outcome among women with sickle cell disease in a tertiary health institution in Abakaliki: a retrospective case-control study. Int J Clin Med. 2019;10(08):395. DOI: https://doi.org/10.4236/ijcm.2019.108032
Galiba Atipo Tsiba FO, Itoua C, Ehourossika C, Ngakegni NY, Buambo G, Potokoue Mpia NSB, et al. Pregnancy outcomes among patients with sickle cell disease in Brazzaville. Anemia. 2020;2020:1989134. DOI: https://doi.org/10.1155/2020/1989134
Vijay C, Fernandes N, Kanavi JV, Teena TM. Maternal and neonatal outcomes with sickle cell disease (SCD) in a tertiary health care hospital in a south Indian Population. Ann Obstet Gynecol. 2021;4(2):1032.
De Sousa VT, Ballas SK, Leite JM, Olivato MCA, Cancado RD. Maternal and perinatal outcomes in pregnant women with sickle cell disease: an update. Hematol Transfus Cell Ther. 2022;44(3):369-73. DOI: https://doi.org/10.1016/j.htct.2020.12.009
Adesina OO, Brunson A, Fisch SC, Yu B, Mahajan A, Willen SM, et al. Pregnancy outcomes in women with sickle cell disease in California. Am J Hematol. 2023;98(3):440-8. DOI: https://doi.org/10.1002/ajh.26818
Early ML, Eke AC, Gemmill A, Lanzkron S, Pecker LH. Comparisons of severe maternal morbidity and other adverse pregnancy outcomes in pregnant people with sickle cell disease versus anemia. JAMA Netw Open. 2023;6(2):e2254545. DOI: https://doi.org/10.1001/jamanetworkopen.2022.54545
Serjeant GR, Loy LL, Crowther M, Hambleton IR, Thame M. Outcome of pregnancy in homozygous sickle cell disease. Obstet Gynecol. 2004;103(6):1278-85. DOI: https://doi.org/10.1097/01.AOG.0000127433.23611.54
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008;148(2):94-101. DOI: https://doi.org/10.7326/0003-4819-148-2-200801150-00004
Neumayr LD, Hoppe CC, Brown C. Sickle cell disease: current treatment and emerging therapies. Am J Manag Care. 2019;25(18 Suppl):S335-43.
Downloads
Published
How to Cite
Issue
Section
